WELLS FARGO & COMPANY/MN - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 15 filers reported holding OCUPHIRE PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$9,856
-22.2%
2,942
+0.8%
0.00%
Q2 2023$12,673
+16.0%
2,920
+0.2%
0.00%
Q1 2023$10,928
+6.3%
2,914
+0.1%
0.00%
Q4 2022$10,279
+71.3%
2,912
+0.1%
0.00%
Q3 2022$6,000
+20.0%
2,908
+0.1%
0.00%
Q2 2022$5,000
-44.4%
2,904
+0.4%
0.00%
Q1 2022$9,0002,892
+2735.3%
0.00%
Q4 2021$0102
+52.2%
0.00%
Q3 2021$067
+1575.0%
0.00%
Q2 2021$040.0%0.00%
Q1 2021$040.0%0.00%
Q4 2020$040.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Regency Capital Management Inc.\DE 15,000$79,0000.06%
Ikarian Capital, LLC 119,551$632,0000.05%
NORRIS PERNE & FRENCH LLP/MI 78,909$417,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 23,445$124,0000.02%
Stokes Family Office, LLC 12,120$64,0000.01%
MARSHALL WACE, LLP 329,131$1,738,0000.01%
Cornerstone Capital, Inc. 11,357$60,0000.01%
MCF Advisors LLC 9,499$50,0000.01%
Cutler Group LLC / CA 7,900$41,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 13,389$71,0000.00%
View complete list of OCUPHIRE PHARMA INC shareholders